Kuzma’s work focuses on the interactions among science, technology and society, particularly the governance of emerging technologies. As a subset of this work, she is interested in public and stakeholder engagement in decision-making about emerging technologies, such as genetic engineering, nanotechnology and synthetic biology. Kuzma regularly works with science museums as a speaker and participant in their science cafes, public forums, and meetings on technology and society, and she serves as an adviser to several public agency groups. She also serves on the Food and Drug Administration’s Blood Product’s Advisory Committee.
In the News
Uses a database and case-study approach to analyze potential future agrifood nanotechnology products, governance and policy issues. Describes “upstream oversight assessment” as a subset of anticipatory governance. Anticipatory governance and UOA are designed to prepare for, not predict, futures of technological governance.